Matelda Zancan

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Giampietro Gasparini, Massimo Gion, Luigi Mariani et al. · Breast Cancer Research and Treatment · 2006 · 135 citations · Full text

Breast Oncology, Phase Ii Trial, Medicine +8

Evaluation of HER-2/neu in Serum and Tissue of Primary and Metastatic Breast Cancer Patients using an Automated Enzyme Immunoassay

Ruggero Dittadi, Matelda Zancan, Antonio Perasole et al. · The International Journal of Biological Markers · 2001 · 37 citations · Full text

Evaluation of cell-free DNA in urine as a marker for bladdercancer diagnosis

Matelda Zancan, Francesca Galdi, F. Di Tonno et al. · The International Journal of Biological Markers · 2009 · 28 citations

Evaluation of Cell-free DNA in Urine as a Marker for Bladder Cancer Diagnosis

Matelda Zancan, Francesca Galdi, F. Di Tonno et al. · The International Journal of Biological Markers · 2009 · 25 citations

Engineering, Healthy Subjects, Dna Analysis +23

Testosterone and Biological Characteristics of Breast Cancers in Postmenopausal Women

Giorgio Secreto, Elisabetta Venturelli, E. Meneghini et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 24 citations